Guggenheim Capital’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Sell |
61,532
-1,959
| -3% | -$35.7K | 0.01% | 843 |
|
|
2025
Q1 | $1.26M | Sell |
63,491
-4,287
| -6% | -$85.1K | 0.01% | 792 |
|
|
2024
Q4 | $1.16M | Buy |
67,778
+57,000
| +529% | +$978K | 0.01% | 841 |
|
|
2024
Q3 | $215K | Buy |
+10,778
| New | +$215K | ﹤0.01% | 1743 |
|
|
2016
Q3 | – | Sell |
-29,747
| Closed | -$177K | – | 2883 |
|
|
2016
Q2 | $177K | Buy |
29,747
+7,929
| +36% | +$47.2K | ﹤0.01% | 2684 |
|
|
2016
Q1 | $177K | Buy |
21,818
+4,286
| +24% | +$34.8K | ﹤0.01% | 2701 |
|
|
2015
Q4 | $142K | Sell |
17,532
-787
| -4% | -$6.37K | ﹤0.01% | 2811 |
|
|
2015
Q3 | $153K | Buy |
+18,319
| New | +$153K | ﹤0.01% | 2768 |
|